Dr. Krikor Hovsep Manoukian, MD

Dr. Manoukian practices at Socal Breathe Free ASC LLC in Burbank, California.

Dr. Manoukian's NPI, 1740519586, was assigned on December 7, 2009. Dr. Manoukian graduated from David Geffen School of Medicine at UCLA in 2008. Dr. Manoukian's California license number on file is A110222.

Dr. Manoukian's primary practice is Socal Breathe Free ASC LLC, at 201 S Buena Vista St, Burbank, CA 91505 in Los Angeles County. The practice phone is (520) 979-6774.

Dr. Manoukian's primary practice is Socal Breathe Free ASC LLC in Burbank, California. Dr. Manoukian is also affiliated with UCI Health - Orange. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Manoukian to 3 more medical groups, 2 physician offices and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manoukian practices, 5 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Manoukian's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Manoukian is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Manoukian's licenses on file in 7 states: California, Florida, Nevada, Illinois, New York, Pennsylvania and Texas.

Dmand AI lists acid reflux, acute sinusitis, aneurysm, arterial blot clot /embolism, asthma, bronchitis, chronic hypertension and chronic nasal allergies among the conditions Dr. Manoukian treats.

CMS data shows 4,295 Medicare services from Dr. Manoukian across 6 procedure codes in 2024, for 169 Medicare patients. Medicare paid $33,428 for them. Every service was in an office.

CMS counts 169 Medicare patients who saw Dr. Manoukian in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 57% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Manoukian's median patient age at 36, with 62% women.

In 2024, Dr. Manoukian wrote 1,532 Medicare Part D claims for 193 patients. 68% of them were for generic drugs. CMS names the drug for 1,391 of them, across 31 drugs with 11 or more claims each, at $697,906 in total drug cost. In 2023, CMS named 1,462 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Manoukian for performance year 2024, reported through an alternative payment model (APM). Dr. Manoukian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manoukian as offering telehealth.

Dmand AI links 1 paper to Dr. Manoukian.

CMS Open Payments shows 522 general payments to Dr. Manoukian from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Optinose US, Inc. paid the most, $3,768.

Dr. Manoukian graduated from David Geffen School of Medicine at UCLA in 2008.

Dr. Manoukian is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.